12.11.2024 09:04:57
|
Alzchem Group new partner of FC Bayern Basketball
Alzchem Group new partner of FC Bayern Basketball Munich, November 12, 2024 – FC Bayern Basketball and Alzchem, a company based in Trostberg, have joined forces for the new season to achieve success together. With Alzchem's premium brand Creapure®, the internationally renowned manufacturer of creatine monohydrate will accompany the German champions on their way through the coming season as an official Gold partner. Creapure® stands for the highest purity and quality in the field of sports nutrition and is recognized by athletes worldwide. As the leading and only Western manufacturer of creatine, Alzchem places particular emphasis on “made in Germany” production and innovative technologies. The partnership with FC Bayern Basketball marks a further milestone in the combination of top athletic performance and high-quality nutrition. “We are pleased to have Creapure® at our side as a partner,” says Adrian Sarmiento, Chief Strategy Officer of FCBB. ”With a reliable partner like Creapure®, we are committed to the highest quality and support the team's performance.” The collaboration includes not only direct support for the two-time champions during the season in the EuroLeague and BBL, but also joint marketing and communication measures to emphasize the importance of sports nutrition and performance enhancement. Creapure® will be visible in the communication in the BMW Park, in the new SAP Garden and on the social media channels of FCBB, offering fans important insights into the world of sports nutrition. “FC Bayern Basketball stands for success, commitment and team spirit – values that Creapure® also embodies,” explains Andreas Niedermaier, CEO of the Alzchem Group. ”We are proud to support the team with creatine of the highest quality and look forward to a successful season.” About Creapure® About FC Bayern Basketball About Alzchem The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023. End of Media Release Issuer: Alzchem Group AG Key word(s): Sports
12.11.2024 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2027527 |
End of News | EQS Media |
|
2027527 12.11.2024 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzungmehr Nachrichten
19.11.24 |
Verluste in Frankfurt: SDAX zum Ende des Dienstagshandels mit Abgaben (finanzen.at) | |
15.11.24 |
EQS-DD: Alzchem Group AG: Dr. Georg Weichselbaumer, buy (EQS Group) | |
15.11.24 |
EQS-DD: Alzchem Group AG: Dr. Georg Weichselbaumer, Kauf (EQS Group) | |
14.11.24 |
EQS-DD: Alzchem Group AG: Andreas Lösler, Kauf (EQS Group) | |
14.11.24 |
EQS-DD: Alzchem Group AG: Andreas Lösler, buy (EQS Group) | |
14.11.24 |
EQS-DD: Alzchem Group AG: Herr Andreas Niedermaier, Kauf (EQS Group) | |
14.11.24 |
EQS-DD: Alzchem Group AG: Herr Andreas Niedermaier, buy (EQS Group) | |
14.11.24 |
EQS-DD: Alzchem Group AG: Klaus Dieter Englmaier, Kauf (EQS Group) |
Analysen zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzungmehr Analysen
11.11.24 | AlzChem Group Add | Baader Bank |